<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Ulriksen Goldman | Activity</title>
	<link>https://toxicdolls.com/members/regretsong02/activity/</link>
	<atom:link href="https://toxicdolls.com/members/regretsong02/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Ulriksen Goldman.</description>
	<lastBuildDate>Mon, 04 May 2026 08:35:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">6c1b1b4fb070d19b86627b0dbf3bd1c4</guid>
				<title>Ulriksen Goldman posted an update: Ongoing quality assurance is essential to ensure appropriate [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/7243/</link>
				<pubDate>Sun, 22 Jun 2025 07:11:33 +0000</pubDate>

									<content:encoded><![CDATA[<p>Ongoing quality assurance is essential to ensure appropriate use of the technology and, most importantly, patient safety. Well-designed studies are needed to determine which patients are most likely to benefit from robot-assisted surgery over other minimally invasive approaches.Anorectal disorders can have overlapping symptoms, which sometimes can&hellip;<span class="activity-read-more" id="activity-read-more-7243"><a href="https://toxicdolls.com/activity-2/p/7243/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">17a1c5433ae8905879b4791909e72ef5</guid>
				<title>Ulriksen Goldman posted an update: ungi. Chemical analysis of the mutants generated by these two [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/6254/</link>
				<pubDate>Sat, 21 Jun 2025 07:44:42 +0000</pubDate>

									<content:encoded><![CDATA[<p>ungi. Chemical analysis of the mutants generated by these two gene editing systems identified the key biosynthetic genes and pathway for the biosynthesis of nematocidal thermolides in T. dupontii Phenotype analysis and chemical stress experiments revealed potential roles of secondary metabolites or their biosynthetic genes in fungal development&hellip;<span class="activity-read-more" id="activity-read-more-6254"><a href="https://toxicdolls.com/activity-2/p/6254/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">690e2bc8e9a2a68a2b33d7b07d3abe59</guid>
				<title>Ulriksen Goldman posted an update: Taken together, our findings indicated that ELFN1-AS1 acted [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/5210/</link>
				<pubDate>Fri, 20 Jun 2025 12:17:10 +0000</pubDate>

									<content:encoded><![CDATA[<p>Taken together, our findings indicated that ELFN1-AS1 acted as an oncogene in ovarian cancer through regulating the expression of CLDN4 by directly interacting with miR-497-3p. <a href="https://www.selleckchem.com/products/tvb-3166.html" rel="nofollow ugc">TVB-3166 clinical trial</a> The results suggested that ELFN1-AS1 might act as a promising therapeutic target for OV.The unbound fractions in plasma (fup) in two mouse models of&hellip;<span class="activity-read-more" id="activity-read-more-5210"><a href="https://toxicdolls.com/activity-2/p/5210/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">06e2ee989e7e447f90c821cdfb0b0a7a</guid>
				<title>Ulriksen Goldman became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/5170/</link>
				<pubDate>Fri, 20 Jun 2025 11:58:54 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>